Clinical Trial Update: A Study of ARGX-110 in Participants With Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ARGX-110 in participants with advanced malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• ARGX-110

Snippet

Sponsor: OncoVerity, Inc. | Conditions: Neoplasms | Phase 1, Phase 2 | Status: COMPLETED